DUBLIN–(BUSINESS WIRE)–The “Companion Diagnostic Markets – the Future of Diagnostics by Funding Source and Application with Customized Forecasting/Analysis, COVID-19 Updates, and Executive and Consultant Guides 2020-2024” report has been added to ResearchAndMarkets.com’s offering.
This report provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2020 United States Medicare Fee Payment Schedules to help understand test pricing in detail. Forecast demand for new testing regimes or technologies. Make research investment decisions. Specific growth and market size estimates for your area of interest is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges.
The report includes detailed breakouts for 18 Countries and 4 Regions. A detailed breakout for any country or specific area in the world is available to purchasers of the report.
Key Topics Covered:
1. Introduction and Market Definition
2. Market Overview
2.1 Players in a Dynamic Market
2.1.1 Academic Research Lab
2.1.2 Diagnostic Test Developer
2.1.3 Instrumentation Supplier
2.1.4 Distributor and Reagent Supplier
2.1.5 Independent Testing Lab
2.1.6 Public National/regional lab
2.1.7 Hospital lab
2.1.8 Physician Office Labs
2.1.9 Audit Body
2.1.10 Certification Body
2.2 Personalized Medicine and Companion Diagnostics
2.2.1 Basics
2.2.2 Method
2.2.3 Disease risk assessment
2.2.4 Applications
2.2.5 Diagnosis and intervention
2.2.5.1 Companion Diagnostics
2.2.6 Drug development and usage
2.2.7 Respiratory proteomics
2.2.8 Cancer genomics
2.2.9 Population screening
2.2.10 Challenges
2.2.11 Regulatory oversight
2.2.12 Intellectual property rights
2.2.13 Reimbursement policies
2.2.14 Patient privacy and confidentiality
2.3 Chromosomes, Genes and Epigenetics
2.3.1 Chromosomes
2.3.2 Genes
2.3.3 Epigenetics
2.4 Cancer Genes
2.4.1 Germline vs Somatic
2.4.2 Changing Clinical Role
2.5 Structure of Industry Plays a Part
2.5.1 New Pharmaceutical Funding Market
2.5.2 Economies of Scale
2.5.2.1 Hospital vs. Central Lab
2.5.3 Physician Office Labs
2.5.4 Physicians and POCT
3. Market Trends
3.1 Factors Driving Growth
3.1.1 Level of Care
3.1.2 Immuno-oncology
3.1.3 Liability
3.1.4 Aging Population
3.2 Factors Limiting Growth
3.2.1 State of knowledge
3.2.2 Genetic Blizzard.
3.2.3 Protocol Resistance
3.2.4 Regulation and coverage
3.3 Instrumentation and Automation
3.3.1 Instruments Key to Market Share
3.3.2 Bioinformatics Plays a Role
3.4 Diagnostic Technology Development
3.4.1 Next Generation Sequencing Fuels a Revolution.
3.4.2 Single Cell Genomics Changes the Picture
3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment
3.4.4 CGES Testing, A Brave New World
3.4.5 Biochips/Giant magnetoresistance based assay
4. Companion Diagnostics Recent Developments
4.1 Recent Developments – Importance and How to Use This Section
4.1.1 Importance of These Developments
4.1.2 How to Use This Section
5. Profiles of Key Players
6. The Global Market for Companion Diagnostics
6.1 Global Market Overview by Country
6.2 Global Market by Application – Overview
6.3 Global Market Funding Source – Overview
7. Global Companion Diagnostic Markets – By Application
7.1 Oncology
7.2 Neurology
7.3 Cardiology
7.4 Other Application
8. Global Companion Diagnostic Markets – Funding Source
8.1 Global Market Pharmaceutical
8.2 Global Market Venture
8.3 Global Market Clinical
8.4 Global Market Other Funding
Companies Mentioned
- Abbott Diagnostics
- AccuraGen Inc
- Adaptive Biotechnologies
- Aethlon Medical
- Agena Bioscience, Inc
- Agilent
- Anchor Dx
- ANGLE plc
- ApoCell, Inc.
- ArcherDx, Inc
- ARUP Laboratories
- Asuragen
- AVIVA Biosciences
- Baylor Miraca Genetics Laboratories
- Beckman Coulter, Inc.
- Becton, Dickinson and Company
- BGI Genomics Co. Ltd
- Bio-Rad Laboratories, Inc
- Bio-Reference Laboratories
- Bio-Techne
- Bioarray Genetics
- Biocartis
- Biocept, Inc
- Biodesix Inc
- BioFluidica
- BioIVT
- Biolidics Ltd
- bioMrieux Diagnostics
- Bioneer Corporation
- Bioview
- Bolidics
- Boreal Genomics
- Bristol-Myers Squibb
- Cancer Genetics
- Caris Molecular Diagnostics
- Castle Biosciences, Inc.
- CellMax Life
- Cepheid (now Danaher)
- Charles River Laboratories
- Chronix Biomedical
- Circulogene
- Clinical Genomics
- Cynvenio
- Cytolumina Technologies Corp
- CytoTrack
- Datar Cancer Genetics Limited
- Diagnologix LLC
- Diasorin S.p.A
- Enzo Life Sciences, Inc
- And Many More Companies!
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900